The AI Cure: Hope or Hubris? Fidji Simo's departure from OpenAI last year sent shockwaves through the tech industry. She had already made a name for herself at Meta, where she took Instacart public.
But what caught everyone off guard was her decision to leave OpenAI and focus on using AI to cure chronic diseases like Postural Orthostatic Tachycardia Syndrome (POTS), which she has battled for seven years.
Simo's post announcing her departure raised more questions than answers, but her promise to use AI to find a cure resonated deeply with those affected by these conditions.